CLEVELAND BIOLABS INC CBLI Income Statement

Cleveland biolabs inc (CBLI)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues:
Grants and contracts
880	922	1,027	1,149	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Grants and contracts
-	-	-	-	-	-	-	-	1,600	1,948	2,067	2,912	3,280	3,518	3,798	3,158	2,913	2,708	2,829	2,742	2,974	3,701	6,183	7,403	8,454	8,487	6,777	5,361	4,006	3,570	3,355	6,936	7,247	8,790	0	0	0	-	-
Operating expenses:
Grants and contracts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Sales Revenue, Net, Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Research and development
1,361	1,656	1,909	2,486	2,796	3,619	4,608	4,688	4,967	5,048	5,682	5,868	5,971	6,496	6,234	7,182	7,473	7,143	8,068	8,084	8,825	9,654	11,448	13,585	16,634	19,525	20,491	21,127	21,847	22,501	22,268	23,949	23,065	22,788	20,524	18,171	0	0	0
General and administrative
1,725	1,817	1,778	1,964	2,066	2,318	2,549	2,412	2,450	2,500	2,607	2,783	2,971	3,378	3,895	4,411	5,231	6,355	7,191	7,711	8,364	8,469	8,701	10,202	10,968	12,038	13,006	13,046	0	-	0	0	-	-	-	-	0	-	-
General and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	0	0
Total operating expenses
3,086	3,474	3,688	4,451	4,862	5,938	7,158	7,101	7,418	7,549	8,290	8,651	8,943	9,874	10,130	11,593	12,705	13,499	15,260	15,795	17,189	18,123	20,149	23,787	27,603	31,564	32,419	32,988	34,019	33,617	34,244	36,945	34,722	33,895	29,702	25,771	0	0	0
Loss from operations
-2,206	-2,552	-2,708	-3,457	-3,753	-4,799	-5,385	-5,314	-5,817	-5,600	-6,222	-5,739	-5,662	-6,355	-6,332	-8,435	-9,791	-10,791	-12,431	-13,052	-14,214	-14,421	-13,966	-16,384	-19,148	-23,076	-25,642	-27,627	-30,012	-30,046	-30,889	-30,009	-27,474	-25,105	-19,668	-15,328	0	0	0
Other income (expense):
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Change in value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Interest and other income (expense)
-670	-681	49	51	49	126	139	191	217	197	84	59	131	263	607	332	128	-99	-440	-275	-818	-1,089	-1,191	-1,024	-352	44	453	426	0	-	0	0	-	-	-	-	0	0	-
Interest and other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0
Foreign exchange gain (loss)
-0	-1	-0	1	3	3	2	-0	-5	-13	258	269	306	362	-227	-450	-418	-509	-896	-955	-928	-1,036	-352	-95	-141	38	24	-239	355	-365	0	0	0	-	0	0	0	-	-
Gain on investment provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in value of warrant liability
-6	-72	-216	-301	-359	-962	-785	-498	3,795	4,426	4,012	2,011	-1,565	-3,099	-3,960	-2,173	-1,240	221	483	1,366	-525	-2,662	-4,016	-6,016	-8,399	-2,864	3,912	2,532	0	-	0	0	-	-	-	-	-	-	-
Equity in loss of Incuron, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-362	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	-	-
Change in value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Total other income (expense)
-664	-610	265	354	411	1,092	927	689	-3,583	-4,241	-3,595	-1,641	2,043	3,765	3,247	993	-225	-2,253	11,738	10,960	12,452	14,457	2,473	4,895	7,904	2,947	8,564	2,844	3,209	7,631	3,946	26,178	0	-	0	0	-	0	0
Net loss
-2,871	-3,162	-2,442	-3,103	-3,342	-3,707	-4,457	-4,625	-9,401	-9,842	-9,818	-7,381	-3,619	-2,590	-3,085	-7,441	-10,017	-13,044	-692	-2,092	-1,762	35	-11,493	-11,488	-11,243	-20,129	-17,077	-24,782	-26,802	-22,414	-32,357	-22,920	-5,883	-5,229	-4,779	-4,429	0	0	0
Net loss
-2,871	-3,162	-2,442	-3,103	-3,342	-3,707	-4,457	-4,625	-9,401	-9,842	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-32,357	-22,920	-5,883	-5,229	-4,779	-4,429	0	0	0
Net loss attributable to noncontrolling interests
-40	-47	-70	-77	-82	-95	-108	-119	-133	-136	-49	-11	35	68	-235	-333	-361	-407	-749	-1,172	-1,326	-1,593	-2,524	-1,485	-2,159	-2,866	-4,273	-6,231	-6,215	-4,180	-2,173	-548	42	-1,216	-379	-655	0	0	0
Net loss attributable to Cleveland BioLabs, Inc.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10,002	-9,083	-17,262	-27,775	-28,762	0	-	0	0	-	-	-	-	-	-	-
Net loss attributable to Cleveland BioLabs, Inc.
-2,830	-3,114	-2,371	-3,026	-3,260	-3,611	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	0	-	-4,025	-3,773	0	0	0
Net loss attributable to common stockholders per share of common stock, basic and diluted (in dollars per share)
-0.05	-0.11	-0.04	-0.05	-0.08	-0.03	-0.10	-0.08	-0.11	-0.11	-0.11	-0.50	-0.15	-0.11	0.10	-0.17	-0.06	0.78	-0.31	-1.12	-1.14	4.19	-1.43	-1.53	-0.63	-7.29	-0.09	-0.07	-0.22	-9.16	-0.30	-0.14	-0.15	-	-	-	-0.19	-	-
Weighted average number of shares used in calculating net loss per share, basic and diluted (in shares)
11,353	11,298	11,298	11,298	11,298	11,298	11,298	11,298	11,280	11,284	11,279	11,218	10,987	10,987	10,987	10,987	10,987	10,887	10,168	3,979	3,206	2,863	2,855	2,594	2,498	-125,835	45,061	44,948	44,826	-99,804	35,879	35,745	35,657	-	-	-	-	-	-
Net income (loss) available to common stockholders per share of common stock, basic (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.08	0.38	-	-0.27	-0.09
Net loss available to common stockholders per share of common stock, basic and diluted (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.08	0.30	-	-0.27	-0.09
Weighted average number of shares used in calculating net income (loss) per share, basic (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35,447	30,033	-	26,984	26,734
Weighted average number of shares used in calculating net loss per share, basic and diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35,447	37,588	-	26,984	26,734
Weighted average number of shares used in calculating net loss per share, basic and diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29,110	-	-